Indications
Therapeutic Asset Ratings
13,145 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Darovasertib
Ocular Melanoma
St Vincent's Hospital, Sydney
P2
B
(57)
Dasatinib
Breast Cancer
National Cancer Institute (NCI)
P2
B
(57)
Dasatinib
Cognitive Disorder
Mayo Clinic
P2
B
(57)
Daunomycin
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
B
(57)
Daunomycin
Core Binding Factor Acute Myeloid Leukemia
National Cancer Institute (NCI)
P2
B
(57)
dd01
Metabolic Dysfunction-Associated Steatotic Liver Disease
Neuraly, Inc.
P2
B
(57)
Decitabine
Childhood Acute Myeloid Leukemia
Children's Hospital of Soochow University
P2
B
(57)
Defactinib
Non-Small Cell Lung Carcinoma
Verastem, Inc.
P2
B
(57)
Defibrotide
Sickle Cell Disease
New York Medical College
P2
B
(57)
Dexasone
Angioimmunoblastic T-Cell Lymphoma
Ou Bai, MD/PHD
P2
B
(57)
Dexasone
Adult T-Cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
P2
B
(57)
Dexasone
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
B
(57)
Dextrose
Ischemic Stroke
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
P2
B
(57)
Dinaciclib
Melanoma
National Cancer Institute (NCI)
P2
B
(57)
Docetaxel
BRCA2-Related Cancer Predisposition
Qian Qin
P2
B
(57)
Docetaxel
Chemotherapy-Induced Neuropathy
Mansoura University
P2
B
(57)
Docetaxel
Gastric Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Docetaxel
Urinary Bladder Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Docetaxel
Uterine Cervix Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Donafenib
Chemotherapy-Induced Toxicity
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
B
(57)
Donafenib
Digestive System Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
B
(57)
Donafenib
Liver And Intrahepatic Bile Duct Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P2
B
(57)
Donanemab
Cognitive Disorder
Eli Lilly and Company
P2
B
(57)
Doxycycline
Non-Small Cell Lung Carcinoma
Janssen Research & Development, LLC
P2
B
(57)
ds-5141b
Duchenne Muscular Dystrophy
Daiichi Sankyo Co., Ltd.
P2
B
(57)
Showing 2776 to 2800 of 13,145 assets
Previous
Page 112 of 526
Next